Harmony Biosciences Holdings, Inc. (HRMY)
27.59
+0.49
(+1.81%)
USD |
NASDAQ |
Mar 25, 16:00
27.08
-0.51
(-1.85%)
Pre-Market: 08:38
Harmony Biosciences Holdings Free Cash Flow : 328.64M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Castle Biosciences, Inc. | 28.33M |
| BioMarin Pharmaceutical, Inc. | 717.02M |
| Amicus Therapeutics, Inc. | 29.85M |
| Iovance Biotherapeutics, Inc. | -336.24M |
| Apellis Pharmaceuticals, Inc. | 45.01M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 126.15M |
| Cash from Investing (Quarterly) | -17.63M |
| Cash from Financing (Quarterly) | -3.015M |
| Free Cash Flow Per Share (Quarterly) | 1.819 |
| Free Cash Flow to Equity (Quarterly) | 98.78M |
| Free Cash Flow to Firm (Quarterly) | 108.75M |
| Free Cash Flow Yield | 20.33% |